Showing results (1271-1280 of 1,297) with videos related to
Sort By:
Pageof 130
Scientific Reports|May 16, 2024
Multi-omic analysis identifies hypoalbuminemia as independent biomarker of poor outcome upon PD-1 blockade in metastatic melanomaLindsay V M Leek, Jessica C L Notohardjo, Karlijn de Joode, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2024
Efficacy of Pembrolizumab and Biomarker Analysis in Patients with WGS-Based Intermediate to High Tumor Mutational Load: Results from the Drug Rediscovery ProtocolBirgit S Geurts, Laurien J Zeverijn, Lindsay V M Leek, et al.Oncology Letters|August 20, 2019
Anti-EpCAM antibodies for detection of metastatic carcinoma in effusions and peritoneal washFabiana Pirani Carneiro, Maria Imaculada Muniz-Junqueira, Marcos De Vasconcelos Carneiro, et al.Nature Medicine|January 8, 2024
Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trialYara L Verschoor, Joris van de Haar, José G van den Berg, et al.JAMA|February 28, 2018
Effect of On-Demand vs Routine Nebulization of Acetylcysteine With Salbutamol on Ventilator-Free Days in Intensive Care Unit Patients Receiving Invasive Ventilation: A Randomized Clinical TrialDavid M P van Meenen, Sophia M van der Hoeven, Jan M Binnekade, et al.Stroke|July 14, 2025
Perinatal Arterial Stroke Treated With Stromal Cells Intranasally: 2-Year Safety and NeurodevelopmentNienke Wagenaar, Lisanne M Baak, Niek E van der Aa, et al.Drugs & Aging|July 21, 2022
Drug Survival, Safety, and Effectiveness of Biologics in Older Patients with Psoriasis: A Comparison with Younger Patients-A BioCAPTURE Registry StudyE L M Ter Haar, S E Thomas, J M P A van den Reek, et al.Nature Genetics|July 4, 2025
The synthetic lethal interaction between CDS1 and CDS2 is a vulnerability in uveal melanoma and across multiple tumor typesPui Ying Chan, Diana Alexander, Ishan Mehta, et al.Cancer Cell|July 4, 2025
Subclonal immune evasion in non-small cell lung cancerKrijn K Dijkstra, Roberto Vendramin, Despoina Karagianni, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2022
Patients with Rare Cancers in the Drug Rediscovery Protocol (DRUP) Benefit from Genomics-Guided TreatmentLouisa R Hoes, Jade M van Berge Henegouwen, Hanneke van der Wijngaart, et al.Pageof 130